Cytochrome p450-dependent metabolites of arachidonic acid and renal function in the rat

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 8, 2000, Pages 581-586

  Oyekan, A O ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Pressure natriuresis; Renal autoregulation

Indexed keywords

CYTOCHROME P450;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTERIAL PRESSURE; ARTICLE; AUTOREGULATION; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NATRIURESIS; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION;

ANIMALS; ANTIFUNGAL AGENTS; ARACHIDONIC ACID; BLOOD PRESSURE; CYTOCHROME P-450 ENZYME SYSTEM; HOMEOSTASIS; HYDROXYEICOSATETRAENOIC ACIDS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MICONAZOLE; NATRIURESIS; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; URODYNAMICS;

EID: 0033945848     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03313.x     Document Type: Article

References (34)

1. 1. Roman RJ, Cowley Jr AW. Abnormal pressure-diuresis-natriuresis response in spontaneously hypertensive rats. Am. J. Physiol. 1985; 248: F199-205.
2. 2. Roman RJ. Pressure diuresis mechanism in the control of renal function and arterial pressure. Fed. Proc. 1986; 45: 2897-903.
3. 2 and renal functions in the Lyon hypertensive rat. Am. J. Physiol. 1994; 266: R1530-6.
4. 4. Hall JE, Mizelle HL, Woods LL. The renin-angiotensin system and long-term regulation of arterial pressure. J. Hypertens. 1986; 4: 387-97.
5. 5. Hirata Y, Hayakawa H, Suzuki E, Omata M. Does endothelin work as an intrarenal mechanism to alter pressure natriuresis in spontaneously hypertensive rats? J. Hypertens. 1994; 12: 251-7.
6. 6. DiBona GF. Neural control of renal function: Cardiovascular implications. Hypertension 1989; 13: 539-48.
7. 7. Mizelle HL, Hall JE, Hildebrandt DA, Montani J-P. Does atrial natiuretic peptide cause chronic natriuresis? Kidney Int. 1989; 35: 285.
8. 8. Hu L, Manning Jr RD. Role of nitric oxide in regulation of long-term pressure natriuresis relationship in Dahl rats. Am. J. Physiol. 1995; 268: H2375-83.
9. 9. Roman RJ, Lianos E. Influence of prostaglandins on papillary blood flow and pressure-natriuretic response. Hypertension 1990; 15: 29-35.
10. 10. Rahman M, Wright Jr JT, Douglas JG. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: A review. Am. J. Hypertens. 1997; 10: 356-65.
11. 11. Escalante B, Sacerdoti D, Davidian MM, Laniado-Schwartzman ML, McGiff JC. Chronic treatment with tin normalizes pressure in spontaneously hypertensive rats. Hypertension 1991; 17: 776-9.
12. 12. Omata K, Abraham NG, Laniado-Schwartzman M. Renal cytochrome P450-arachidonic acid metabolism: Localization and hormonal regulation in SHR. Am. J. Physiol. 1992; 262: F591-9.
13. 13. Imig JD, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450. Hypertension 1993; 22: 357-64.
14. 14. Ma YH, Schwartzman ML, Roman RJ. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am. J. Physiol. 1994; 267: R579-89.
15. 15. Oyekan AO, McAward K, Conetta J, Rosenfeld L, McGiff JC. Endothelin-1 and cytochrome P450 arachidonate metabolites interact to promote tissue injury in DOCA/salt hypertension. Am. J. Physiol. 1999; 276: R766-75.
16. 16. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 1989; 243: 388-90.
17. 17. Zou A-P, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z-H, Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol. 1994a; 266: F275-82.
18. 18. Zou A-P, Imig JD, Kaldunski M et al. Effect of P450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am. J. Physiol. 1994; 266: F934-41.
19. 19. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 1991; 251: 799-802.
20. 20. Takahashi K, Capdevilla J, Karara A, Falck JR, Jacobson HR, Badr KF. Cytochrome P450 arachidonate metabolites in rat kidney: Characterization and hemodynamic responses. Am. J. Physiol. 1990; 258: F781-9.
21. 21. Imig JD, Zou A-P, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 1996; 270: R217-27.
22. 22. Navar LG, Majid DS. Interactions between arterial pressure and sodium excretion. Curr. Opin. Nephrol. Hypertens. 1996; 5: 64-71.
23. 23. Wang M-H, Brand-Schieber E, Zand BA et al. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors. J. Pharmacol. Exp. Ther. 1998; 284: 966-73.
24. 24. Oyekan AO, McGiff JC. Cytochrome P450-derived eicosanoids participate in the renal functional effects of endothelin-1 in the anaesthetized rat. Am. J. Physiol. 1998; 274: R52-61.
25. 25. Zou A-P, Ma Y-H, Ortiz de Montellano PR, Clark JE, Masters BS, Roman RJ. Effects of 17-ODYA, a suicide-substrate inhibitor of fatty acid ω-hydroxylase on renal function in rats. J. Pharmacol. Exp. Ther. 1994; 268: 474-81.
26. 26. Takenaka T, Suzuki H, Sakamaki Y, Saruta T. Contribution of prostaglandins to pressure natriuresis in Dahl salt-sensitive rats. Am. J. Hypertens. 1991; 4: 489-93.
27. 27. Evans RG, Day KH, Roman RJ, Hopp KH, Anderson WP. Effects of intrarenal infusion of 17-octadecynoic acid on renal antihypertensive mechanisms in anesthetized rabbits. Am. J. Hypertens. 1998; 11: 803-12.
28. 28. Iwai N, Inagami T. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension 1991; 17: 161-9.
29. 29. Zou A-P, Muirhead EE, Cowley Jr AW et al. Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension. J. Hypertens. 1995; 13: 557-66.
30. 30. Thomas CJ, Woods RL, Evans RG et al. Evidence for a renomedullary vasodepressor hormone. Clin. Exp. Pharmacol. Physiol. 1996; 23: 777-85.
31. 31. Strick DM, Fiksen-Olsen MJ, Carretero OA, Romero JC. Renal kinin antagonism does not impair pressure-induced natriuresis. Am. J. Physiol. 1992; 263: F77-82.
32. 32. Romero MF, Madhun ZT, Hopfer U, Douglas JC. An epoxygenase metabolite of arachidonic acid 5,6-epoxyeicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium. Adv. Prostaglandin Thromboxane Leukot. Res. 1991; 21: 205-8.
33. 33. Carroll MA, Balazy MB, Margiotta P, Falck JR, McGiff JC. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J. Biol. Chem. 1993; 268: 12260-6.
34. 34. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevilla JH. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J. Clin. Invest. 1994; 94: 2414-20.